IC
PDLI

IEQ Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

IEQ Capital’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-71,023
Closed -$224K – 431
2020
Q3 		$224K Hold
71,023
– – 0.01% 347
2020
Q2 		$207K Hold
71,023
– – 0.01% 291
2020
Q1 		$200K Sell
71,023
-63,715
-47% -$205K 0.02% 339
2019
Q4 		$437K Buy
+134,738
New +$391K 0.04% 235

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

IEQ Capital's PDLI Position: Q4 2020 in Review

IEQ Capital sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 71,023 shares — an estimated $224K sold.

IEQ Capital first reported a position in PDLI in Q4 2019 and held it in 4 quarters. The position peaked at $437K in Q4 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • IEQ Capital reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • IEQ Capital sold 71,023 PDL BioPharma, Inc. shares in Q4 2020, an estimated $224K.
  • IEQ Capital first reported a position in PDL BioPharma, Inc. in Q4 2019 and held it in 4 quarters.
  • IEQ Capital's PDL BioPharma, Inc. position peaked at $437K in Q4 2019.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on IEQ Capital's 13F filing for Q4 2020, filed 3 Feb 2021.